Navigation Links
Louisiana Tech biomedical engineering professor earns recognition, funding for research
Date:7/12/2012

RUSTON, La. Dr. Teresa Murray, assistant professor in biomedical engineering at Louisiana Tech University, has received notice from the National Institute of Health (NIH) that her proposal titled "Long Term 3D Imaging of Mouse Brain in Vivo to Study Glial Cells and Gliogenesis" was recognized for excellence and will receive funding.

NIH ranks proposals on a scale from 10 90, with 10 being the best. Murray's proposal received an 11.

Dr. Eric Guilbeau, director of biomedical engineering at Louisiana Tech, says receiving the NIH funding is exceptional. "For a first time NIH grant submission, this is an outstanding accomplishment. It places [Murray's] proposal at the very top of those considered by her NIH Study Section, which is a rare occurrence for a new faculty member, especially in these days of tight funding."

Murray's research focuses on Glial cells, which greatly outnumber neurons in the brain and have active roles in development, modulation of neurotransmission, health and disease. However, relatively little is known about glial cells compared to neurons. Murray is working to create a tool for researchers to discover how glial cells in the brain function and how they are involved in aging and disorders such as Alzheimer's and Parkinson's diseases.

Murray has created a tiny glass lens with needle-like diameter. Using a microscope to look into the lens, researchers will be able to record the numbers and shapes of the cells by illuminating a fluorescent dye to determine if there are major changes in aging or certain diseases, and if potential treatments return them to a normal state.

The lens will enable Murray and her students and collaborators to resolve fine membrane processes of glial cells as they interact with neurons. This would produce useful information with which to study normal development and aging, or the effects of drug use, neurodegeneration, or injury.

It is hoped that this project will result in a new technology to enable high resolution, three-dimensional, imaging of fluorescently labeled glial cells deep in the brain over the time course of months. This concerted approach will streamline experiments, enable unparalleled comparative analysis, increase confidence in experimental results, and elucidate interactions not possible using multiple, discrete experiments.


'/>"/>
Contact: Dave Guerin
dguerin@latech.edu
318-257-4854
Louisiana Tech University
Source:Eurekalert

Related medicine news :

1. Louisiana Tech University professor earns NSF Early Career Development grant
2. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
3. InsuranceCalculator.net Now Provides Competitive Car Insurance Quotes To Louisiana Drivers
4. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
5. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
6. Biomedical researchers receive Hartwell Foundation awards
7. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
8. UMMS researcher Victor Ambros, Ph.D., named co-recipient of 2012 Janssen Award for Biomedical Research
9. Rising Solar Engineering and Design Firm Enters 1.7 MW's in Connecticut ZREC Auction and Positions for Future Growth
10. Cells derived from debrided burn tissue may be useful for tissue engineering
11. Clemson professor awarded nearly $600,000 4-year grant to study language of plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... insight into the challenges employers face in trying to balance both short-term and ... benefits programs? Adding to the growing complexity, companies are finding that the ...
(Date:3/29/2017)... (PRWEB) , ... March 29, ... ... Manufacturer Alliance (GRMA) is growing as it continues developing an ANSI-approved, consensus-based ... industry. The organization, which plans to publish the first ANSI-approved GMP standard ...
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... The assembly of synthetic DNA ... many repetitive steps and often scientists require many different versions of DNA. Therefore, ... results in a lower error rate and cost saving for reagents and consumables. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)...  Maxor National Pharmacy Services, LLC ("Maxor"), a leading ... Leah Bailey as General Counsel.  Bailey will serve ... With more than 13 years of experience ... on health care, Bailey joins the Maxor team coming ... advised the PBM, Specialty, and Mail Order business areas ...
(Date:3/29/2017)... , March 29, 2017 Varian Medical Systems ... report results for the second quarter of fiscal year 2017 ... 2017.  The news release will be followed by a teleconference ... news release and a link to the conference call webcast ... .  To access the teleconference call and replay: ...
Breaking Medicine Technology: